How often can I administer Monofer (iron sucrose) intravenous infusion?

Monofer (Iron Isomaltoside) Dosing Frequency

Monofer can be repeated when iron deficiency anemia recurs, with laboratory reassessment recommended 4-8 weeks after the initial infusion to guide redosing decisions. 1

FDA-Approved Dosing Schedule

The FDA label for Monofer explicitly states: "Repeat dose if iron deficiency anemia reoccurs" for both weight categories 1:

• Patients ≥50 kg: 1,000 mg as a single dose over at least 20 minutes
• Patients <50 kg: 20 mg/kg as a single dose over at least 20 minutes

When to Reassess and Redose

Laboratory monitoring should occur 4-8 weeks after the last infusion to determine if repeat dosing is needed 2. This timing is critical because:

• Iron parameters (ferritin, transferrin saturation) should not be checked within 4 weeks of infusion, as circulating iron interferes with assays and produces spurious results 2
• Hemoglobin should increase by 1-2 g/dL within 4-8 weeks of therapy 2
• Target ferritin is ≥50 ng/mL (in absence of inflammation) 2

Frequency Depends on Underlying Cause

The redosing interval is condition-dependent 2:

Single Dose May Suffice If:

• The cause of iron deficiency has been eliminated
• No ongoing blood loss exists
• Iron absorption is normal

Repeated Dosing Required For:

• Ongoing blood losses: Heavy menstrual bleeding, angiodysplasia, hereditary hemorrhagic telangiectasia, inflammatory bowel disease
• Malabsorption conditions: Post-bariatric surgery, autoimmune gastritis, celiac disease
• Active inflammation: Inflammatory bowel disease with compromised absorption 3

The frequency in these scenarios depends on the degree of blood loss or malabsorption and must be individualized based on serial laboratory monitoring 2.

Practical Algorithm

1. Administer initial Monofer dose (1,000 mg or 20 mg/kg)
2. Wait 4-8 weeks before checking labs
3. Assess response: CBC, ferritin, transferrin saturation
4. Redose if:
   • Hemoglobin has not increased by 1-2 g/dL
   • Ferritin remains <50 ng/mL
   • Transferrin saturation <20%
   • Anemia has recurred

Safety Considerations

Monitor for hypersensitivity reactions for at least 30 minutes after each infusion and ensure resuscitation equipment is immediately available 1. Serious hypersensitivity reactions occurred in 0.3% of patients in clinical trials 1. Avoid iron overload by monitoring iron parameters before each redose 1.

Advantages of Monofer Over Other Formulations

Monofer allows single-dose total iron replacement up to 1,000 mg (or 20 mg/kg up to 1,500 mg), eliminating the need for multiple visits required with iron sucrose (which is limited to 200 mg per dose) 2, 3. This improves adherence and reduces infusion reaction risk compared to multi-dose regimens 2.